Palleon packs $100m into series B

Sep 18, 2020 • Robert Lavine

SR One, AbbVie Ventures, Takeda Ventures and Pfizer Ventures all returned for the cancer and inflammatory disease drug developer's series B.

Palleon Pharmaceuticals, a US-based immunotherapy developer based on research at Stanford and Dundee University, closed a $100m series B round yesterday led by Matrix Capital Management.
Pharmaceutical firms GlaxoSmithKline, Pfizer, Takeda and AbbVie participated through subsidiaries SR One, Pfizer Ventures, Takeda Ventures and AbbVie Ventures.
The round also attracted Vertex Ventures HC, a healthcare and life sciences fund that forms part of venture capital group Vertex Ventures, and Surveyor Capital, the growth equity arm of investment manager Citadel.

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.

Find out more

2024 marks flurry of university spinout fund launches

University venture funds are becoming an increasingly important tool for universities to support their ecosystems — here are the new ones launched in 2024.

12 groundbreaking global university spinouts that raised funding in 2024

Our pick of spinout technologies that are breaking new ground in plastics recycling, data storage, photonics, semiconductor materials and decoding the genome.

8 tips for investing in Japan’s university spinouts

Japan has a well-funded and vibrant market for deep tech companies spun out of its universities. Here are some of the quirks that foreign investors seeking to dip a toe into the sector should look out for.

Events

Webinar: Designing a winning CVC platform – Engagement, venture development, operations

Jan 15, 2025
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

Jan 28 -
Jan 29, 2025
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

Mar 17 -
Mar 18, 2025
Palo Alto, CA (USA)

Find out more All events

Events

GCVI Summit 2025

Mar 18 -
Mar 20, 2025
Monterey, CA (USA)

Find out more All events

Events

GCV Institute: CVC Investment Programs

Apr 8 -
Apr 10, 2025
Online

Find out more All events

Events

GCV Institute: Landing the Value of Corporate Venturing

Apr 24 -
Jun 12, 2025
Online

Find out more All events

Events

GCV Symposium 2025

Jun 17 -
Jun 19, 2025
London (UK)

Find out more All events

About us

Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.